Literature DB >> 27956029

Molecular mechanisms of deregulation of the thin filament associated with the R167H and K168E substitutions in tropomyosin Tpm1.1.

Yurii S Borovikov1, Nikita A Rysev2, Stanislava V Avrova2, Olga E Karpicheva2, Danuta Borys3, Joanna Moraczewska3.   

Abstract

Point mutations R167H and K168E in tropomyosin Tpm1.1 (TM) disturb Ca2+-dependent regulation of the actomyosin ATPase. To understand mechanisms of this defect we studied multistep changes in mobility and spatial arrangement of tropomyosin, actin and myosin heads during the ATPase cycle in reconstituted ghost fibres using the polarized fluorescence microscopy. It was found that both mutations disturbed the mode of troponin operation in the fibres. At high Ca2+, troponin increased the fraction of actin monomers that were in the "switched on" state, but both mutant tropomyosins were shifted toward the outer actin domains, which decreased the fraction of strongly bound myosin heads throughout the ATPase cycle. At low Ca2+, the R167H-TM was located close to the outer actin domains, which reduced the number of strongly-bound myosin heads. However, under these conditions troponin increased the number of actin monomers that were switched on. The K168E-TM was displaced far to the outer actin domains and troponin binding decreased the fraction of switched on actin monomers, but the proportion of the strongly bound myosin heads was abnormally high. Thus, the mutations differently disturbed transmission of conformational changes between troponin, tropomyosin and actin, which is essential for the Са2+-dependent regulation of the thin filament.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Congenital myopathies; F-actin; Fluorescence polarization; Ghost muscle fibres; Myosin; Tropomyosin; Troponin

Mesh:

Substances:

Year:  2016        PMID: 27956029     DOI: 10.1016/j.abb.2016.12.004

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  3 in total

1.  Molecular Mechanisms of Muscle Weakness Associated with E173A Mutation in Tpm3.12. Troponin Ca2+ Sensitivity Inhibitor W7 Can Reduce the Damaging Effect of This Mutation.

Authors:  Yurii S Borovikov; Armen O Simonyan; Stanislava V Avrova; Vladimir V Sirenko; Charles S Redwood; Olga E Karpicheva
Journal:  Int J Mol Sci       Date:  2020-06-22       Impact factor: 5.923

2.  Molecular Mechanisms of the Deregulation of Muscle Contraction Induced by the R90P Mutation in Tpm3.12 and the Weakening of This Effect by BDM and W7.

Authors:  Yurii S Borovikov; Daria D Andreeva; Stanislava V Avrova; Vladimir V Sirenko; Armen O Simonyan; Charles S Redwood; Olga E Karpicheva
Journal:  Int J Mol Sci       Date:  2021-06-12       Impact factor: 5.923

3.  Molecular mechanisms of dysfunction of muscle fibres associated with Glu139 deletion in TPM2 gene.

Authors:  Yurii S Borovikov; Nikita A Rysev; Olga E Karpicheva; Vladimir V Sirenko; Stanislava V Avrova; Adam Piers; Charles S Redwood
Journal:  Sci Rep       Date:  2017-12-01       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.